Back
ESC Premium Access

Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study

Session: Poster session 7 - Prevention general
Topic: Primary cardiovascular prevention: interventions and outcomes
Speaker: Professor F. Saad (Berlin, DE)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Farid Saad

Bayer AG, Berlin (Germany)
0 follower

27 more presentations in this session

Enhanced cardiovascular susceptibility to air pollution: A 4 years echocardiographic study of pulmonary circulation.

Speaker: Professor J. Argacha (Brussels, BE)

Access
Abstract
Slides
Like
Thumbnail

Systemic inflammatory response in chronic venous disorders and their clinical relevance in the general population.

Speaker: Doctor N. Arnold (Mainz, DE)

Access
Abstract
Like
Thumbnail

The hemoglobin A1C and creatinine are associated with coronary calcium score for female but not male in a general low risk population

Speaker: Doctor J. Wu (Toufen, TW)

Access
Abstract
Slides
Like
Thumbnail

ABCA1 gene polymorphism InsG319 prevents the development of impaired glucose tolerance in young and middle-aged women

Speaker: Professor S. Boldueva (Saint Petersburg, RU)

Access
Abstract
Like
Thumbnail

Andexanet alfa reduces betrixaban-induced blood loss in a rabbit liver laceration model of acute bleeding.

Speaker: Doctor P. Conley (South San Francisco, US)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 7 - Prevention general

Speakers: Professor F. Saad, Professor J. Argacha, Doctor N. Arnold, Doctor J. Wu, Professor S. Boldueva...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources